Exos TFP Holdings’s Frazier Lifesciences Acquisition Corporation Warrant FLACW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-133,486
Closed -$100K 701
2022
Q3
$100K Buy
+133,486
New +$84.7K 0.05% 272

Exos TFP Holdings's FLACW Position: Q4 2022 in Review

Exos TFP Holdings sold out of Frazier Lifesciences Acquisition Corporation Warrant (FLACW) in Q4 2022, closing a stake of 133,486 shares — an estimated $100K sold.

Exos TFP Holdings first reported a position in FLACW in Q3 2022 and held it in 1 quarter. The position peaked at $100K in Q3 2022. 0 funds tracked by Wall St. Rank hold FLACW as of Q4 2022.

  • Exos TFP Holdings reported no remaining Frazier Lifesciences Acquisition Corporation Warrant position as of Q4 2022 after selling out during the quarter.
  • Exos TFP Holdings sold 133,486 Frazier Lifesciences Acquisition Corporation Warrant shares in Q4 2022, an estimated $100K.
  • Exos TFP Holdings first reported a position in Frazier Lifesciences Acquisition Corporation Warrant in Q3 2022 and held it in 1 quarter.
  • Exos TFP Holdings's Frazier Lifesciences Acquisition Corporation Warrant position peaked at $100K in Q3 2022.
  • 0 funds tracked by Wall St. Rank held Frazier Lifesciences Acquisition Corporation Warrant as of Q4 2022.

Based on Exos TFP Holdings's 13F filing for Q4 2022, filed 10 Feb 2023.